December 14, 2018Open Access

Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

TIL levels in TNBC RD are significantly associated with improved RFS and OS and add further prognostic information to RCB class, particularly in RCB class II.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Luen et al. (Fri,) studied this question.

synapsesocial.com/papers/69dd08fe34612599f33596ba https://doi.org/https://doi.org/10.1093/annonc/mdy547

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis2014 · 4,723 citations
2Abstract S1-03: Pooled individual patient data analysis of stromal tumor infiltrating lymphocytes in primary triple negative breast cancer treated with anthracycline-based chemotherapy2016 · 33 citations
3Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study2014 · 465 citations
4T-cell invigoration to tumour burden ratio associated with anti-PD-1 response2017 · 1,659 citations
5Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy2007 · 1,668 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo